Physician

David M Pierce, M.D.

According to 2025 Medicare claims, David Pierce, M.D. (NPI: 1245312057) practices family practice in the Valdosta, GA market, with the plurality of this provider's patient population coming from Lowndes, GA. This provider's primary affiliated billing organization is VALDOSTA FAMILY MEDICINE ASSOCIATES, P.C. (NPI: 1114003779; TIN: 581844895) and primary practice location at 31602-2567. Pierce is affiliated with the Physicians First ACO LLC (ACO ID: A5509), participating under the MSSP model.

Pierce's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 695 traditional Medicare patients, billed 8,834 HCPCS/CPT codes, and received $202,107 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,419 prescription claims across 849 beneficiaries totaling $836,942 in drug costs, led by Ozempic (Semaglutide). DME data shows 386 claims. Open Payments data shows 22 records totaling $210. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $313,933 to $836,942. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $22,223 and ending at $22,566.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	797	7,637	$211,504
2016	679	7,541	$198,360
2017	650	7,725	$192,020
2018	655	6,905	$163,650
2019	689	7,138	$185,276
2020	625	6,159	$159,493
2021	671	7,129	$198,903
2022	703	7,088	$195,852
2023	682	7,140	$194,845
2024	695	8,834	$202,107

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	507	6,684	$313,933
2016	537	7,365	$355,017
2017	511	6,595	$325,473
2018	544	7,541	$416,815
2019	549	6,846	$381,083
2020	530	7,204	$424,460
2021	590	7,322	$533,838
2022	685	7,769	$629,199
2023	781	8,018	$641,572
2024	849	9,419	$836,942

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	103	342	$12,845
2016	124	432	$8,523
2017	133	544	$12,665
2018	115	477	$13,009
2019	98	434	$10,752
2020	102	351	$11,547
2021	122	376	$13,007
2022	116	369	$11,223
2023	142	372	$13,784
2024	128	386	$19,239

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	378	562	$77
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	334	491	$11
80053	Blood test, comprehensive group of blood chemicals	293	364	$10
36415	Insertion of needle into vein for collection of blood sample	381	717	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	253	306	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	90	3,136	$91,843
Eliquis	Apixaban	85	4,150	$81,163
Mounjaro	Tirzepatide	66	2,016	$72,735
Januvia	Sitagliptin Phosphate	66	3,100	$55,679
Farxiga	Dapagliflozin Propanediol	56	2,330	$42,869

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	15	$5,430
A7030	Full face mask used with positive airway pressure device, each	N	17	34	$2,786
A7031	Face mask interface, replacement for full face mask, each	N	13	24	$1,880
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	55	$1,714
K0823	Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds	Y	N/R	12	$1,714

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$210	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David M. Pierce, M.D.?

Tedicare shows public-source Medicare data for David M. Pierce, M.D. (NPI 1245312057), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David M. Pierce, M.D. have ACO affiliation data?

David M. Pierce, M.D. is shown with ACO affiliation data for Physicians First ACO LLC (MSSP, ACO ID A5509).

What billing organization is linked to David M. Pierce, M.D.?

David M. Pierce, M.D. is linked to VALDOSTA FAMILY MEDICINE ASSOCIATES, P.C. (billing NPI 1114003779) in the available physician profile data.

Does David M. Pierce, M.D. have Open Payments data?

David M. Pierce, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.